Integrated Advisors Network’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,873
| Closed | -$213K | – | 724 |
|
2024
Q4 | $213K | Buy |
+2,873
| New | +$213K | 0.01% | 654 |
|
2024
Q3 | – | Sell |
-4,497
| Closed | -$415K | – | 711 |
|
2024
Q2 | $415K | Sell |
4,497
-9,282
| -67% | -$857K | 0.02% | 493 |
|
2024
Q1 | $1.32M | Buy |
13,779
+8,214
| +148% | +$785K | 0.07% | 257 |
|
2023
Q4 | $424K | Sell |
5,565
-452
| -8% | -$34.5K | 0.02% | 475 |
|
2023
Q3 | $417K | Sell |
6,017
-16,201
| -73% | -$1.12M | 0.03% | 463 |
|
2023
Q2 | $2.1M | Sell |
22,218
-932
| -4% | -$87.9K | 0.12% | 193 |
|
2023
Q1 | $1.92M | Buy |
23,150
+299
| +1% | +$24.7K | 0.12% | 192 |
|
2022
Q4 | $1.7M | Buy |
22,851
+4,409
| +24% | +$329K | 0.11% | 203 |
|
2022
Q3 | $1.52M | Sell |
18,442
-287
| -2% | -$23.7K | 0.1% | 203 |
|
2022
Q2 | $1.78M | Buy |
18,729
+11,268
| +151% | +$1.07M | 0.12% | 197 |
|
2022
Q1 | $878K | Sell |
7,461
-28
| -0.4% | -$3.3K | 0.05% | 331 |
|
2021
Q4 | $970K | Buy |
7,489
+154
| +2% | +$19.9K | 0.06% | 293 |
|
2021
Q3 | $830K | Buy |
7,335
+509
| +7% | +$57.6K | 0.06% | 304 |
|
2021
Q2 | $707K | Buy |
6,826
+105
| +2% | +$10.9K | 0.05% | 291 |
|
2021
Q1 | $562K | Buy |
6,721
+270
| +4% | +$22.6K | 0.05% | 312 |
|
2020
Q4 | $589K | Buy |
6,451
+20
| +0.3% | +$1.83K | 0.06% | 259 |
|
2020
Q3 | $513K | Buy |
6,431
+29
| +0.5% | +$2.31K | 0.06% | 247 |
|
2020
Q2 | $443K | Buy |
6,402
+243
| +4% | +$16.8K | 0.05% | 275 |
|
2020
Q1 | $387K | Sell |
6,159
-36
| -0.6% | -$2.26K | 0.08% | 221 |
|
2019
Q4 | $482K | Buy |
+6,195
| New | +$482K | 0.07% | 252 |
|